Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction

Sponsor
Manuel Sanchez Luna (Other)
Overall Status
Recruiting
CT.gov ID
NCT05918016
Collaborator
(none)
360
1
105
3.4

Study Details

Study Description

Brief Summary

Observational study of preterm infant with a gestational age < 30 weeks born between 2017-2023 in Neonatal Care Unit in Gregorio Marañon Hospital (Madrid, Spain). We use a new ultrasonographic prognostic scale of periventricular hemorrhagic infarction for neurodevelopmental outcome at age 2 years.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Routine cranial ultrasounds

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
360 participants
Observational Model:
Case-Control
Time Perspective:
Other
Official Title:
Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction in Preterm Infants With Gestational Age <30 Weeks
Actual Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Jul 31, 2023
Anticipated Study Completion Date :
Oct 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Periventricular Hemorrhagic Infarction [first month]

    Yes or no

  2. Characteristic Sonographic [first month]

  3. Neurodevelopmental outcome at age 2 years [first month]

Secondary Outcome Measures

  1. Medical records [first month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Gestacional Age < 30 weeks
Exclusion Criteria:
  • Brain malformation

  • Genetic syndrome

  • Metabolic disorders

  • Chromosomal abnormality

  • None cranial ultrasound

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gregorio Marañon Hospital Madrid Spain 28007

Sponsors and Collaborators

  • Manuel Sanchez Luna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manuel Sanchez Luna, Doctor, Hospital General Universitario Gregorio Marañon
ClinicalTrials.gov Identifier:
NCT05918016
Other Study ID Numbers:
  • Neuro.Neo.1.IVH
First Posted:
Jun 26, 2023
Last Update Posted:
Jun 26, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 26, 2023